Vertex Pharmaceuticals Inc: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
102.05 Mil |
| Income |
-641.58 Mil |
| Net Profit Margin |
-628.70% |
| Return on Equity |
-96.06% |
| Debt/Equity Ratio |
0.14 |
|
| Revenue/Share |
0.59 |
| Earnings/Share |
-3.73 |
| Book Value/Share |
5.49 |
| Dividend Rate |
0.00 |
| Payout Ratio |
NA |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 24.0 | 41.7 | 68.8 |
| 2nd Qtr | 19.1 | 69.4 | 38.2 |
| 3rd Qtr | 25.0 | 31.6 | 41.0 |
| 4th Qtr | NA | 32.8 | 51.0 |
| Total | 68.0 | 175.5 | 199.0 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | -$1.04 | -$0.72 | -$0.64 |
| 2nd Qtr | -$0.99 | -$0.66 | -$0.91 |
| 3rd Qtr | -$0.84 | -$0.93 | -$0.82 |
| 4th Qtr | NA | -$0.96 | -$0.66 |
| Total | -$2.87 | -$3.27 | -$3.03 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | -8% | -9% | --- |
| 2nd Qtr | 5% | 8% | -42% |
| 3rd Qtr | 15% | -41% | 10% |
| 4th Qtr | NA | -3% | 20% |
| Yr. over Yr. EPS Growth Rate |
| FY (12/09) | FY (12/08) |
|---|
| 1st Qtr | -44% | -13% |
| 2nd Qtr | -50% | 27% |
| 3rd Qtr | 10% | -13% |
| 4th Qtr | NA | -45% |
advertisement
Recent News